top of page

Ketamine for Treatment Resistant MDD

About the study

NCT Trial Number

NCT04021433

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Hadassah Medical Organization

noun_date_3237048.png

Trial Start Date

Sep-18

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

No

The study is the safety, tolerability and effectiveness of repeated, individually tailored ketamine for treatment resistant major depression

Eyes Graffiti

Locations

Israel
Hadassah Hebrew University Medical Center
Jerusalem, Israel

Contact: Moshe Isserles, MD
00972 2 6777184
moshay@hadassah.org.il

Contact: Hadas Lamberg, PhD
00 972 2 6777572
lhadas@hadassah.org.il

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page